Your ADHD child fidgets and squirms his way through school and homework, but seems laser-focused and motionless sitting in front of the TV watching an action thriller. Well, fret not, because new research shows lack of motivation or boredom with school isn’t to blame for the differing behavior. It turns out that symptoms of Attention Deficit Hyperactivity Disorder such as fidgeting, foot-tapping and chair-swiveling are triggered by cognitively demanding tasks – like school and homework. But movies and video games don’t typically require brain strain, so the excessive movement doesn’t manifest.

Many parents are elated when their child starts walking before crawling, excited that he or she bypassed a step in the developmental process. But is this actually good? Could it create challenges for children, especially ones who are eventually diagnosed with attention deficit hyperactivity disorder?

The US Food and Drug Administration (FDA) has approved amphetamine extended-release oral suspension (Adzenys ER, Neos Therapeutics Inc) for attention-deficit/hyperactivity disorder (ADHD) in children aged 6 years and older, the company has announced. The FDA has already approved Neos Therapeutics' amphetamine extended-release orally disintegrating tablets (Adzenys XR-ODT) and the company's methylphenidate extended-release orally disintegrating tablets (Cotempla XR-ODT) for ADHD in children aged 6 years and older.

Despite several recent advancements in the space, adults with attention deficit/hyperactivity disorder (ADHD) continue to report experiencing considerable burden throughout the day and a desire for longer acting medications...Researchers conducted an online survey of adults with ADHD who had been taking prescription psychostimulant medications to determine how their current medications were tackling their ADHD symptoms.

Mydayis’ debut this weekend at the 30th US Psychiatric and Mental Health Congress in New Orleans, Louisiana, came after more than a decade of studies for the treatment for attention deficit hyperactivity disorder (ADHD). During the meeting, Shire PLC presented consolidated data involving adults aged 18 to 55 years; in June, FDA approved the drug for patients as young as 13. The drug has the same active ingredient as Adderall XR, but works up to 16 hours through a 3-bead technology that releases amphetamine in the stomach and at points in the small intestine over several hours.

There’s no such thing as ADHD. ADHD is just a matter of willpower. Smart people don’t have ADHD. According to attention deficit hyperactivity disorder experts, these and other thoughts are among the top myths associated with ADHD. Edward Hallowell, founder of the Hallowell Centers, which helps treat people with ADHD and other cognitive and emotional conditions in Boston, New York City, San Francisco and Seattle, says holding tight to such thoughts does a disservice to the ADHD population.

The symptoms of ADHD foster important traits associated with entrepreneurship. That conclusion was reached in a study conducted by an international team of economists, who found that entrepreneurs with ADHD embrace new experiences and demonstrate passion and persistence.

A new five-year program aims to enhance early detection strategies and improve treatment for children who have both Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder. Funded by the National Institutes of Health, the $12.5 million program will focus on improving treatment for patients with both disabilities by analyzing the connection between them. The initiative is intended to gain more information about the effects of having both autism and ADHD—a combination that scientists say warrants more research.

Parenting a child with ADHD isn’t always easy. Because every child with ADHD is unique and comes with a different set of challenges, there isn’t a roadmap to tell you what to do...The following are six things parents of children with ADHD wish that someone had told them when their child was diagnosed.